BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2038315)

  • 1. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
    Hsu HL; Cheng JT; Chen Q; Baer R
    Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding properties of basic helix-loop-helix fusion proteins of Tal and E47.
    Ghosh I; Bishop P; Chmielewski J
    J Pept Res; 2001 May; 57(5):354-60. PubMed ID: 11350595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
    Goldfarb AN; Lewandowska K
    Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
    Miyamoto A; Cui X; Naumovski L; Cleary ML
    Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
    O'Neil J; Billa M; Oikemus S; Kelliher M
    Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.
    Voronova A; Baltimore D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4722-6. PubMed ID: 2112746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
    Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
    Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A versatile expression vector for the in vitro study of protein-protein interactions: characterization of E47 mutant proteins.
    Hainzl T; Boehm T
    Oncogene; 1994 Mar; 9(3):885-91. PubMed ID: 8108132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A third tal-1 promoter is specifically used in human T cell leukemias.
    Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
    J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among vertebrate helix-loop-helix proteins in yeast using the two-hybrid system.
    Staudinger J; Perry M; Elledge SJ; Olson EN
    J Biol Chem; 1993 Mar; 268(7):4608-11. PubMed ID: 8383120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
    Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
    Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.
    Park ST; Sun XH
    J Biol Chem; 1998 Mar; 273(12):7030-7. PubMed ID: 9507011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning.
    Nielsen AL; Pallisgaard N; Pedersen FS; Jørgensen P
    Mol Cell Biol; 1992 Aug; 12(8):3449-59. PubMed ID: 1321336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a highly conserved module in E proteins required for in vivo helix-loop-helix dimerization.
    Goldfarb AN; Lewandowska K; Pennell CA
    J Biol Chem; 1998 Jan; 273(5):2866-73. PubMed ID: 9446597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCL assembles a multifactorial complex that determines glycophorin A expression.
    Lahlil R; Lécuyer E; Herblot S; Hoang T
    Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.